MedPath

Targeted RT study: preliminary results on acute toxicity of targeted therapies and radiotherapy

Recruiting
Conditions
all malignant diseases which are treated with targeted therapy
Registration Number
DRKS00026193
Lead Sponsor
Friedrich-Baur-Stiftung
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
500
Inclusion Criteria

targeted therapy - simultaneously and sequentially with radiation therapy

Exclusion Criteria

none

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prospective systematic recording of the toxicity profile of targeted drugs during radiotherapy in a registry to improve the evidence base.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath